Biography:
Sergey Suchkov was born in the City of Astrakhan, Russia in a family of dynasty medical doctors. In 1980 he graduated from Astrakhan State Medical University and was awarded with MD. In 1985, Suchkov maintained his PhD as a PhD student of the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology. In 2001, Suchkov maintained his Doctor Degree at the National Institute of Immunology, Russia. From 1989 through 1995, Dr Suchkov was being a Head of the Lab of Clinical Immunology, Helmholtz Eye Research Institute in Moscow. From 1995 through 2004 a Chair of the Dept for Clinical Immunology, Moscow Clinical Research Institute (MONIKI). In 1993-1996, Dr Suchkov was a Secretary-in-Chief of the Editorial Board, Biomedical Science an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK.
At present, Dr Sergey Suchkov, MD, PhD, is:
● Director for Center of Biodesign of N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Moscow, Russia
● Senior Scientific Advisor of China Hong Kong Innovation International Business Association, Hong Kong
● R&D Director of InMedStar, Russia Member of the:
● Russian Academy of Natural Sciences, Moscow, Russia
● New York Academy of Sciences, USA
● American Chemical Society (ACS), USA
● American Heart Association (AHA), USA
● European Association for Medical Education (AMEE), Dundee, UK
● EPMA (European Association for Predictive, Preventive and Personalized Medicine), Brussels, EU
● ARVO (American Association for Research in Vision and Ophthalmology);
● ISER (International Society for Eye Research)
● Personalized Medicine Coalition (PMC), Washington, DC, USA


Title : The promise of nanotechnology in personalized and precision pulmonology (PPP): Lung bioengineering and clinical translation in PPP guided practice
Title : Personalized and precision oncology (PPO) to be set up via a precision oncology strategy for the cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety